7-methyl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one | 3201-02-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 7-methyl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one
• 英文别名: 3-methyl-1-benzosuberone；7-methyl-6,7,8,9-tetrahydro-benzocyclohepten-5-one；7-Methyl-6,7,8,9-tetrahydro-benzocyclohepten-5-on；7-methyl-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-one；3-Methyl-6,7-benzsuberon-1；7-methyl-6,7,8,9-tetrahydrobenzo[7]annulen-5-one
• CAS: 3201-02-3
• 化学式: C₁₂H₁₄O
• 分子量: 174.243
• InChiKey: ZNLXRJHYESJJKM-UHFFFAOYSA-N

物化性质

• 沸点：
  152 °C(Press: 19 Torr)
• 密度：
  1.021±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  7-methyl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 生成 7-methyl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-ol
  参考文献：
  名称：

  The Synthesis and Study of Pseudo-Aromatic Compounds. V. The Synthesis of 3,4-Benzoheptafulvene, 1,2-Benzoheptafulvene, and 8-Phenyl-1,2-benzoheptafulvene¹

  摘要：

  DOI：

  10.1021/ja01094a033
• 作为产物：
  描述：

  5-phenyl-3-methyl-2-pentanoic acid 在 PPA 作用下， 反应 1.0h， 生成 7-methyl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one
  参考文献：
  名称：

  Substituted guanidine derivatives and process for producing the same

  摘要：

  通式（1）所代表的化合物： 其中R1、R2、R3、R4和R5中的每一个是氢原子、烷基、取代烷基、烯基、炔基、环烷基、环烯基、饱和杂环基、芳香基、酰基或类似物；Y1、Y2、Y3和Y4中的每一个是单键、—CH2—、—O—、—CO—或类似物，前提是至少两个Y1到Y4中的独立团是单键以外的团；以及Z可以不存在，或者一个或多个Z可以存在且独立地是烷基、取代烷基、烯基、炔基、环烷基、环烯基、饱和杂环基、卤素原子、羧基、烷氧羰基、芳香基、酰基或类似物，对于由于钠/质子交换传输系统加速而引起的疾病，具有治疗或预防作用。

  公开号：

  US06369110B1

文献信息

• Substituted guanidine derivatives and process for producing the same
  申请人：Sumitomo Pharmaceuticals Company

  公开号：US06369110B1

  公开（公告）日：2002-04-09

  A compound represented by the general formula (1): wherein each of R1, R2, R3, R4 and R5 is a hydrogen atom, an alkyl group, a substituted alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a cycloalkenyl group, a saturated heterocyclic group, an aromatic group, an acyl group or the like; each of Y1, Y2, Y3 and Y4 is a single bond, —CH2—, —O—, —CO— or the like, provided that at least two of Y1 through Y4 are independently a group other than a single bond; and Z may be absent, or one or more Zs may be present and are independently an alkyl group, a substituted alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a cycloalkenyl group, a saturated heterocyclic group, a halogen atom, a carboxyl group, an alkoxycarbonyl group, an aromatic group, an acyl group or the like, is useful as a therapeutic or prophylactic agent for diseases caused by the acceleration of the sodium/proton exchange transport system.

  通式（1）所代表的化合物： 其中R1、R2、R3、R4和R5中的每一个是氢原子、烷基、取代烷基、烯基、炔基、环烷基、环烯基、饱和杂环基、芳香基、酰基或类似物；Y1、Y2、Y3和Y4中的每一个是单键、—CH2—、—O—、—CO—或类似物，前提是至少两个Y1到Y4中的独立团是单键以外的团；以及Z可以不存在，或者一个或多个Z可以存在且独立地是烷基、取代烷基、烯基、炔基、环烷基、环烯基、饱和杂环基、卤素原子、羧基、烷氧羰基、芳香基、酰基或类似物，对于由于钠/质子交换传输系统加速而引起的疾病，具有治疗或预防作用。
• A photo-reagent system of benzimidazoline and Ru(bpy)3Cl2 to promote hexenyl radical cyclization and Dowd–Beckwith ring-expansion of α-halomethyl-substituted benzocyclic 1-alkanones
  作者：Eietsu Hasegawa、Minami Tateyama、Tsuneaki Hoshi、Taku Ohta、Eiji Tayama、Hajime Iwamoto、Shin-ya Takizawa、Shigeru Murata

  DOI：10.1016/j.tet.2014.02.078

  日期：2014.4

  undergo 5-exo hexenyl cyclization as well as sequential cyclization and ring-expansion (Dowd–Beckwith) reactions to form radicals that abstract hydrogen atoms from the radical cation of DMBIH to yield the observed products. The results of a study of the effects of substituents located on the 2-aryl ring of DMBIH suggest that steric and hydrogen-bonding interactions influence the nature of the reaction

  2-芳基取代的1,3-二甲基苯并咪唑啉（DMBIHs）和氯化三（2,2'-联吡啶）钌（II），Ru（bpy）3 Cl 2的组合用于促进光致电子转移（PET ）α-卤代甲基取代的苯并环1-链烷酮的反应。这种光试剂系统可刺激自由基的形成，即未被羰基活化的碳溴键和碳氯键的裂解。产生的自由基经历5- exo己烯基环化以及顺序环化和扩环（Dowd-Beckwith）反应形成自由基，该自由基从DMBIH的阳离子中提取氢原子，从而产生可观察到的产物。对位于DMBIH的2-芳基环上的取代基的影响的研究结果表明，空间和氢键相互作用会影响反应途径的性质，进而影响自由基中间体的作用。还研究了使用铱配合物和DMBIH的PET反应。
• Cooperative Catalysis Approach to Intramolecular Hydroacylation
  作者：Evgeny V. Beletskiy、Ch. Sudheer、Christopher J. Douglas

  DOI：10.1021/jo300779q

  日期：2012.7.20

  examples of hydroacylation to form six- and seven-membered ring ketones require either embedded chelating groups or other substrate design strategies to circumvent competitive aldehyde decarbonylation. A cooperative catalysis strategy enabled intramolecular hydroacylation of disubstituted alkenes to form seven- and six-membered rings without requiring substrate-embedded chelating groups.

  形成六元和七元环酮的加氢酰化的现有实例需要嵌入的螯合基团或其他底物设计策略来规避竞争性醛脱羰。协同催化策略使双取代烯烃的分子内加氢酰化反应可形成七元环和六元环，而无需嵌入基质的螯合基团。
• NOVEL SUBSTITUTED GUANIDINE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME
  申请人：Sumitomo Pharmaceuticals Company, Limited

  公开号：EP1083166A1

  公开（公告）日：2001-03-14

  Compounds represented by general formula (1) which are useful as remedies and preventives for diseases caused by acceleration in the sodium/proton exchange system, wherein R1, R2, R3, R4 and R5 represent each hydrogen, alkyl, substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, a saturated aromatic ring, acyl, etc.; Y1, Y2, Y3 and Y4 represent each a single bond, -CH2-, -O-, -CO-, etc., provided that at least two of Y1 to Y4 represent each a group other than a single bond; and Z may be absent or one or more Zs may be present and each represents alkyl, substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, a saturated aromatic ring, halogeno, carboxy, alkoxycarbonyl, an aromatic group, acyl, etc.

  通式(1)所代表的化合物，可作为钠/质子交换系统加速引起的疾病的治疗剂和预防剂，其中R1、R2、R3、R4和R5各自代表氢、烷基、取代烷基、烯基、炔基、环烷基、环烯基、饱和芳环、酰基等；Y1、Y2、Y3和Y4各自代表单键、-CH2-、-O-、-CO-等、条件是 Y1 至 Y4 中至少有两个分别代表单键以外的基团；Z 可以不存在，也可以存在一个或多个 Z，且各自代表烷基、取代烷基、烯基、炔基、环烷基、环烯基、饱和芳香环、卤素、羧基、烷氧羰基、芳香基、酰基等。
• Photochemical processes in substituted 3,4-benzotropilidenes
  作者：K.A. Burdett、F.L. Shenton、D.H. Yates、J.S. Swenton

  DOI：10.1016/s0040-4020(01)97339-9

  日期：1974.1